P0901 MRI radiomic phenotypes stratify response and define immune states in very highrisk non–muscle-invasive bladder cancer treated with tislelizumab plus nabpaclitaxel

European Urology 2026

View at publisher

Authors: S. Huang, Chong Shen, H. Hu

DOI: 10.1016/s0302-2838(26)01760-4

Cited by: 0

Fields of Study & Subjects

Radiomics and Machine Learning in Medical Imaging Bladder and Urothelial Cancer Treatments Cancer Immunotherapy and Biomarkers